Gyre Therapeutics to Participate in Upcoming September Investor Conferences
Gyre Therapeutics management will participate in fireside chats at two September investor conferences in New York: the Cantor Global Healthcare Conference on September 9, 2026 at 9:45 a.m. ET and the Morgan Stanley Healthcare Conference on September 16, 2026 at 1:05 p.m. ET. Both chats will be webcast live, with replays archived for 30 days on the investor relations section of the Gyre website.
Key figures
- F351 nda status
- NDA accepted by China NMPA in May 2026 for CHB-induced liver fibrosis
- Ownership as of
- June 30, 2026
- Gyre pharmaceuticals ownership
- 69.7%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.